4D Molecular Therapeutics, Inc. (FDMT)

9.72 -0.19 (-1.92%) USD  |  NASDAQ  |  Jun 01, 16:00
9.71 -0.01 (-0.10%) After-Hours: 20:00
More

4D Molecular Therapeutics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for FDMT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Perspective Therapeutics, Inc. Upgrade
Agenus, Inc. Upgrade
Amgen, Inc. Upgrade
Anika Therapeutics, Inc. Upgrade
BioCryst Pharmaceuticals, Inc. Upgrade